Cargando…

The Cost-Effectiveness of Personalized Genetic Medicine: The case of genetic testing in neonatal diabetes

OBJECTIVE: Neonatal diabetes mellitus is a rare form of diabetes diagnosed in infancy. Nearly half of patients with permanent neonatal diabetes have mutations in the genes for the ATP-sensitive potassium channel (KCNJ11 and ABCC8) that allow switching from insulin to sulfonylurea therapy. Although t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greeley, Siri Atma W., John, Priya M., Winn, Aaron N., Ornelas, Joseph, Lipton, Rebecca B., Philipson, Louis H., Bell, Graeme I., Huang, Elbert S.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041194/ https://www.ncbi.nlm.nih.gov/pubmed/21273495 http://dx.doi.org/10.2337/dc10-1616

Ejemplares similares

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
por: Naylor, Rochelle N., et al.
Publicado: (2014)

Genetics and pathophysiology of neonatal diabetes mellitus
por: Naylor, Rochelle N, et al.
Publicado: (2011)

SAT-129 Examining the Role of Genetic Testing in Early Onset Diabetes Occurring After 6 Months of Age
por: McCauley, Mary, et al.
Publicado: (2019)

Early Intensive Insulin Use May Preserve β-Cell Function in Neonatal Diabetes Due to Mutations in the Proinsulin Gene
por: Letourneau, Lisa R., et al.
Publicado: (2017)

Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide: A previously unreported side effect
por: Kumaraguru, Janani, et al.
Publicado: (2009)

Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes
por: Dalgin, Gokhan, et al.
Publicado: (2021)

SUN-143 Does a Monogenic Diabetes Diagnosis Impact Quality of Life?
por: Harris, Anastasia, et al.
Publicado: (2019)

Inheritance of Mildly Activating ABCC8 Mutation From a Mother With MODY Causes Permanent Neonatal Diabetes Mellitus (NDM) in Two Siblings Who Also Carry a Second Inactivating Mutation: Genetic Testing Allows for Improved Treatment With Sulfonylureas (SU)
por: Salguero Bermonth, Maria Victoria, et al.
Publicado: (2021)

Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum
por: Riddle, Matthew C., et al.
Publicado: (2020)

SAT083 Comparing Grit, Anxiety, And Social Responsiveness In KCNJ11-NDM And Their Sibling Controls
por: Desai, Jui, et al.
Publicado: (2023)

Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene
por: Støy, Julie, et al.
Publicado: (2010)

Erratum to: Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene
por: Støy, Julie, et al.
Publicado: (2011)

Acute Recurrent Pancreatitis in a Child With INS-Related Monogenic Diabetes and a Heterozygous Pathogenic CFTR Mutation
por: Son, Rachel G, et al.
Publicado: (2022)

Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
por: Bowden, Tiana L., et al.
Publicado: (2021)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation
por: Philla, Katherine Q., et al.
Publicado: (2013)

LBODP084 Bilateral Cataracts In A 15-year-old Girl With New-onset Type 1 Diabetes Mellitus
por: Gunaratne, Naiomi C, et al.
Publicado: (2022)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
por: Philla, Katherine Q., et al.
Publicado: (2014)

Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis
por: Letourneau, Lisa R., et al.
Publicado: (2017)

Role of Noninsulin Therapies Alone or in Combination in Chromosome 6q24-Related Transient Neonatal Diabetes: Sulfonylurea Improves but Does Not Always Normalize Insulin Secretion
por: Carmody, David, et al.
Publicado: (2015)

Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
por: Shah, Reshma P., et al.
Publicado: (2012)

SAT-266 A Retrospective Study Investigating the Association Between ADHD and Glycemic Control in Children and Adolescents with Type 1 Diabetes Mellitus
por: Kolluri, Harini, et al.
Publicado: (2019)

MON-009 The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
por: GoodSmith, Matthew, et al.
Publicado: (2019)

Implementation and utilization of genetic testing in personalized medicine
por: Abul-Husn, Noura S, et al.
Publicado: (2014)

Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas
por: Wright, Jordan J., et al.
Publicado: (2023)

Direct-to-Consumer Genetic Testing's Red Herring: “Genetic Ancestry” and Personalized Medicine
por: Blell, Mwenza, et al.
Publicado: (2019)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

Stroke genetics: prospects for personalized medicine
por: Markus, Hugh S
Publicado: (2012)

Genetics and Vaccines in the Era of Personalized Medicine
por: Castiblanco, John, et al.
Publicado: (2015)

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)
por: Gregory, Justin M., et al.
Publicado: (2019)

Novel KDM6A Kabuki Syndrome Mutation With Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension Requiring ECMO
por: Salguero, Maria V, et al.
Publicado: (2022)

The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
por: Huang, Elbert S., et al.
Publicado: (2010)

Genetic Testing for Neonatal Respiratory Disease
por: Nogee, Lawrence M., et al.
Publicado: (2021)

The intersection of pharmacology, imaging, and genetics in the development of personalized medicine
por: Gerretsen, Philip, et al.
Publicado: (2009)

Genetic heterogeneity in breast cancer: the road to personalized medicine?
por: Baird, Richard D, et al.
Publicado: (2013)

Asthma pharmacogenetics and the development of genetic profiles for personalized medicine
por: Ortega, Victor E, et al.
Publicado: (2015)

Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine
por: Aronica, Lucia, et al.
Publicado: (2022)

Perception of personalized medicine, pharmacogenomics, and genetic testing among undergraduates in Hong Kong
por: Cheung, Nicholas Yan Chai, et al.
Publicado: (2021)

Impact of Genetic Testing on Human Health:: The Current Landscape and Future for Personalized Medicine
por: Funanage, Vicky L.
Publicado: (2021)

Readiness to Accept Genetic Testing for Personalized Medicine: Survey Findings on the Role of Socio-Demographic Characteristics, Health Vulnerabilities, Perceived Genetic Risk and Personality Factors
por: Leppin, Anja, et al.
Publicado: (2022)

Genetic Testing Protocol Reduces Costs and Increases Rate of Genetic Diagnosis in Infants with Congenital Heart Disease
por: Geddes, Gabrielle C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_spes8u7691nnki7apmht92qtov